Login

TI Ref No :	522906121
Description :	Open House Pharmaceutical Discounts On The Active Ingredient Natalizumab, S.c. Daring Form, Atc L04ag03, 67304 Eisenberg Rhineland-palatinate
Date :	2025-09-17
Deadline :	2026-03-16
Document Type :	Tenders